Characterization of dermatomyositis with coexistence of anti-Jo-1 and anti-SRP antibodies

Internal Medicine

Volumn 51, Issue 7, 2012, Pages 799-802

  Sugie, Kazuma ^a   Tonomura, Yasuyo ^a   Ueno, Satoshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti Jo 1 antibody; Anti SRP antibody; Dermatomyositis; Idiopathic inflammatory myopathy; Myositis specific autoantibody; Pleural effusion

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN; COMPLEMENT MEMBRANE ATTACK COMPLEX; CREATINE KINASE; JO 1 ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PREDNISONE; SIGNAL RECOGNITION PARTICLE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CD4 CD8 RATIO; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DERMATOMYOSITIS; DRUG DOSE REDUCTION; DYSPNEA; EDEMA; ELECTROMYOGRAPHY; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LIVER METASTASIS; MALE; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPULE; PLEURA EFFUSION; RASH; SKIN DISCOLORATION; STOMACH CANCER;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; DERMATOMYOSITIS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUSCLE WEAKNESS; PLEURAL EFFUSION; SIGNAL RECOGNITION PARTICLE;

EID: 84859336241     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.51.6566     Document Type: Article

References (10)

1. Targoff IN. Autoantibodies and their significance in myositis. Curr Rheumatol Rep 10: 333-340, 2008.
2. Schmidt WA, Wetzel W, Friedländer R, et al. Clinical and serological aspects of patients with anti-Jo-1 antibodies-an evolving spectrum of disease manifestations. Clin Rheumatol 19: 371-377, 2000.
3. Miller T, Al-Lozi MT, Lopate G, Pestronk A. Myopathy with antibodies to the signal recognition particle: clinical and pathological features. J Neurol Neurosurg Psychiatry 73: 420-428, 2002.
4. Vincze M, Molnár PA, Tumpek J, et al. An unusual association: anti-Jo-1 and anti-SRP antibodies in the serum of a patient with polymyositis. Clin Rheumatol 29: 811-814, 2010.
5. Emslie-Smith AM, Arahata K, Engel AG. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol 20: 224-231, 1989.
6. Emslie-Smith AM, Engel AG. Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration. Neurology 41: 936-939, 1991.
7. Váncsa A, Gergely L, Ponyi A, et al. Myositis-specific and myositis-associated antibodies in overlap myositis in comparison to primary dermatopolymyositis: Relevance for clinical classification: retrospective study of 169 patients. Joint Bone Spine 77: 125-130, 2010.
8. Leff RL, Burgess SH, Miller FW, et al. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies. Arthritis Rheum 34: 1391-1396, 1991.
9. Takada T, Hirakata M, Suwa A, et al. Clinical and histopathological features of myopathies in Japanese patients with anti-SRP autoantibodies. Mod Rheumatol 19: 156-164, 2009.
10. Miyata M, Fukaya E, Takagi T, et al. Two patients with polymyositis and dermatomyositis complicated with massive pleural effusion. Intern Med 37: 1058-1063, 1998.